2022 Conference

25th European GERPAC Conference

October 5, 6 & 7, 2022 - Hyères - France

In this space, you will find all the congress communications including conferences, round table, short oral communications and poster presentations.

Access to all communications requires that you are up to date with your annual GERPAC membership.

Opening of the conference

Concurrent workshops

Training and Evaluation

European Experience Round Table: Improving the stability of reconstituted injectable solutions

Paediatrics

Allergology

Hot topics 2022 Hospital Pharmaceutical Technologies

GERPAC 2022 Multimedia support Contest

Pharmaceutical Technology Master course’s award

GERPAC award 2022 for the best oral communication

Short oral communications

Moderators Y. Huon (Liège - Belgique)
F. Lagarce (Angers - France)
F. Sadeghipour (Lausanne - Suisse)
Comparative study of sorption phenomena between syringes made of cyclic olefin copolymer or polypropylene and three medications. J. Claves1, P. Chennell1, N. Krautwurst2, V. Sautou1
1 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF,
F-63000 Clermont-Ferrand, France
2 SCHOTT Schweiz AG, St. Josefen-Strasse 20, 9001 St. Gallen, Switzerland
ValiStab®, a new tool to help carry out a physicochemical stability study D’Huart E.1,2, Vigneron J.1,2, Demore B.1,2,3.
1 Pharmacie à Usage Intérieur, Hôpitaux de Brabois, 54511 Vandœuvre-lès-Nancy, France.
2 Infostab, non-profit association, Heillecourt, France
3 Université de Lorraine, EA 4360 APEMAC, Nancy, France.
Development of a Letermovir oral solution for anti-cytomegalovirus prophylaxis in children C. Devant, A. Schweitzer-Chaput, P. Marchadour, A-S. Fauqueur, C. Cotteret, S. Cisternino
Pharmacy - University Hospital Necker - Enfants Malades, APHP, Paris Cité University, Paris, France
Biological stability of Pembrolizumab after dilution and storage in 0.9% NaCl infusion polyolefin bags A. Acramel1,2, G. Le Guyader3,4, K. Avrillon4, L. Guyonnet5, J. Denizeau6,7, L. Escalup1, R. Desmaris1, E. Piaggio6,7, C. Guerin5, C. Sedlik6,7
1 Institut Curie, PSL Research University, Pharmacie Department, F-75005 Paris, France
2 Université Paris Cité, CiTCoM, UMR8038 CNRS, U1268 Inserm, F-75006 Paris, France
3 APHP, Hôpital Henri Mondor, Pharmacie, F-94090 Créteil, France
4 Centre Hospitalier Intercommunal de Créteil, Pharmacie, F-94000 Créteil, France
5 Institut Curie, Cytometry Platform, F-75005 Paris, France
6 Institut Curie, PSL Research University, Translational Research Department, F-75005 Paris, France
7 Inserm U932, F-75005 Paris, France
Creation and implementation of an enabling blended learning course in a quality control laboratory M. Stoops1, R. Mazet1, M Durand1, J. Leenhardt1,2, M-D. Desruet1,2, P. Bedouch1,3
1. Département de Pharmacie, Centre Hospitalier Universitaire Grenoble Alpes, France
2. Laboratoire de Bioclinique Radiopharmacie, Université Grenoble Alpes, France
3. ThEMAS, TIMC UMR CNRS 5525, Université Grenoble Alpes, France
Capillary electrophoresis in parenteral nutrition control – Validation of two analytical method: Amino acids/Glucose/Glucose-1-Phosphate and Ka/Na/Ca/Mg C Fanjeaux, R Vazquez, MN Guerrault-Moro, AC Lagrave
Service Pharmacie, Centre Hospitalier Intercommunal Poissy-Saint-Germain-en-Laye
Alertness of in-process controls: feedback on two production errors A. Cataldi1, C. Fanjeaux1, R. Vazquez1, M-N. Guerrault-Moro1, A-C. Lagrave1
1 Service Pharmacie, Centre Hospitalier Intercommunal Poissy-Saint-Germain-en-Laye, France
Chemotherapy manufacturing in a rescue unit for 6 months: a big challenge ! C. Renzullo1, J. Lombardi1, J-F. Penaud1,B. Leroy1, F. Plassard2, S. Kirche3, J. Coutet1 1 Pharmacie
2 Services Techniques
3 Biomédical
Centre Hospitalier de Chalon Sur Saône, 4 rue du Capitaine Drillien, France
Validation of a compounding process for injectable dopamine in an anaerobic chamber for a clinical trial B. Palas1, D. Lannoy1,2, N. Carta2, C. Nassar1, M. Roche1,2, P. Odou1,2
1- Pharmacie CHU Lille, France ; 2- Laboratoire de Biopharmacie, Pharmacie Galénique et Hospitalière, UFR3S, Univ Lille, France
Formulation of an oral phosphorus solution adapted to neonatology J. Convert1, R. Mazet1, F. Basset1, A. Moussali1, S. Chanoine1,2, M. Durand1, M.D. Desruet1, P. Bedouch1,2
1. Pôle Pharmacie, Centre Hospitalo-Universitaire Grenoble Alpes, Grenoble, France
2. Université Grenoble Alpes, Faculté de. Pharmacie, TIMC UMR CNRS 5525, Grenoble, France
Endotoxin assay optimization and validation in binary parenteral nutrition mixtures L. Bourgue, M. Teppe, A. Benhabib, L. Gayrard, M. Ben Reguiga
Service Pharmacie, Centre Hospitalier de Mayotte - 97600 Mayotte
Implementation of a discrimination strategy for eight monoclonal antibodies by FIA-UV using a confusion matrix: application to pembrolizumab J. Siboni1, B.Muhiu1, C. Mequinion1, A. Sifaoui1, E. Caudron1,2, L. Lê 1,2
1 Service de Pharmacie, Hôpital européen Georges Pompidou, APHP Centre Université de Paris, France
2 Equipe Lip(Sys)² Chimie analytique pharmaceutique, Faculté de Pharmacie, Université Paris Saclay, Chatenay-Malabry, France
Efficiency of decontamination procedures for surfaces contaminated with hazardous drugs N. Clottens., P. Ramaut, T. Bauters
Pharmacy dpt., Ghent University Hospital, C. Heymanslaan 10, Ghent, Belgium
Isolator seal breach: assessment of the leak test relevance and impact on microbiological contamination risk G. Guilanpour, E. Gasperi, F. Bordet, M-L. Maestroni
Service Pharmacie, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
Formulation and bioavilability study of a gemcitabine intravesical thermoreversible gel for bladder carcinoma treatment E. Vissac1, Z. Mokdadi1, M. Venet1, M. Colombel3, C. Marchand1, C. Merienne1, Fabrice Pirot1,2 1 Hospices Civils de Lyon - Unité de Préparation et de Contrôle des Médicaments, plateforme FRIPHARM, Pharmacie à usage intérieur, Groupement Hospitalier Edouard Herriot 2 Hospices Civils de Lyon - Pharmacie à usage intérieur, Groupement Hospitalier Edouard Herriot 3 Service d’Urologie, Hospices Civils de Lyon - Faculté de Médecine Lyon Est, France Evaluation of UV-light-shielding bags efficiency on dacarbazine photodegradation M. Sangnier1, J-M. Bernadou1, M. Noguero1, G. Bouguéon1,2, A. Berroneau1, S. Crauste-Manciet1,2
1 Pharmaceutical Technology Department, Bordeaux University Hospital, Avenue de Magellan, 33604 Pessac, France
2 ARNA Laboratoire ChemBioPharm U1212 INSERM - UMR 5320 CNRS, Université de Bordeaux, France
Aerosolisation’s risk assessment of bacteriophages handled in a biological safety cabinet B. Lapras1,4,C. Moreau1, M. Medina2,4, C. Marchand1,4, C. Merienne1,4, C. Kolenda2,4, T. Briot3,4, G. Leboucher3,4, F. Laurent2,4, F. Pirot1,4
1 Plateforme FRIPHARM, Pharmacie à usage intérieur, Groupement Hospitalier Centre - Hospices Civils de Lyon (HCL)
2 Laboratoire de bactériologie, Centre national de référence des staphylocoques – Hospices Civils de Lyon
3 Pharmacie à usage intérieur, Groupement Hospitalier Nord – Hospices Civils de Lyon
4 Consortium PHAG-ONE – PHAGinLyon
Determination of the residual hemolytic activity of a purified bacteriophage suspension M. Pichon-Pramil1, B. Lapras1, M. Medina2, M. Cristofoli1, C. Marchand1, C. Merienne1, F. Laurent2, F. Pirot1
1 Unité de Préparation et de Contrôle des Médicaments, plateforme FRIPHARM, Pharmacie à Usage Intérieur, Groupement Hospitalier Edouard Herriot – Hospices Civils de Lyon
2 Institut des Agents Infectieux, Laboratoire de Biologie et d’Anatomie Pathologique, Groupement Hospitalier Croix Rousse - Hospices Civils de Lyon
Monitoring of surface chemical contamination in a robotized chemotherapy preparation process M. Bouchfaa1,2, A. Lecoutre1, J. Courtin1, M. Pinturaud1, M. Vasseur1,2, S. Nicolas1,2, P. Odou1,2
1- CHU Lille, Institut de pharmacie, F-59000 Lille, France
2- Univ. Lille, EA 7365 – GRITA – Groupe de Recherches sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
Formulation and evaluation of physicochemical stability of Allopurinol 20mg/mL oral suspension V. Baillieu, P. Claraz, C. Sanchez, S. Benakouche, J. Le Liboux, V. Vasseur, T. Storme, A. Sabri
Hôpital Robert Debré, 48 Bd Sérurier, 75019 Paris, France
Visual facilitation of procedures in the cytotoxic reconstitution unit (CRU) A.Charlier, H.Rucheton, C.Nowak, I.Baudin
Pharmacie - Centre Hospitalier d’Angoulême - France
Update on osmolality of oral medications and enteral nutrition used in neonatal department A. Hlavaty1, R. Mazet1, M. Durand1, S. Chanoine1,2, MD. Desruet1 , P. Bedouch1,2
1 - Pôle Pharmacie, Centre Hospitalo-Universitaire Grenoble Alpes, France
2 - TIMC UMR CNRS 5525, Université Grenoble Alpes, France

E-Posters session A: Analytical - Control - Microbiology

Analytical validation of a cation assay in binary parenteral nutrition with capillary electrophoresis T. Pillot, M. Dumas, D. Reitter, N. Chouaou, P. Aouizerate, R. Tang, C. Cuvelier, S. Coulon
Grand hôpital de l’Est francilien, Jossigny, France
Development and validation of a dosing method for colchicine capsules for a stability study N. Kervella, A. Bourges, V. Lebreton
CHU d’Angers, France
Isothermal cases qualified by the suppliers: are-they suitable for the transport of heat-sensitive cytotoxic preparations? E. Allouis, M. Renault-Mahieux, E. Malluile, V. Vieillard, W. Saeed, S. Marque, M. Paul, M. Carvalho
Hôpital Henri Mondor, Créteil, France
Development and validation of a method for the quantitative determination of baclofen and its degradation products for the stability study of experimental medicine Z. Mokdadi, E. Vissac, M. Venet, C. Marchand, C. Dhelens, C. Merienne, F. Pirot
Hôpital Edouard Herriot, Lyon, France
Development and validation of a method for the quantitative determination of baclofen and its degradation products for the stability study of experimental medicine. Z. Mokdadi1, E. Vissac1, M. Venet1, C. Marchand1, C. Dhelens1, C. Merienne1, F. Pirot1, 2
[1] : Pharmacie, Hôpital Edouard Herriot, Lyon France
[2] : Laboratoire de Pharmacie Galénique Industrielle, ISPB, Lyon, France
Development and validation of sterility method by membrane filtration of 5% vancomycin eye drops L. Rodrigo, M. Bourget, E. Olivier, N. Cormier
CHU de Nantes Hôtel-Dieu, France
Validation of an assay method for riboflavin hospital capsule preparation B. Querin, A. Schweitzer Chaput, P. Ober, A. Fauqueur, A. Negbane, S. Cisternino, C. Cotteret
Hôpital Universitaire Necker - Enfants Malades, Paris, France
Determination of ions in paediatric NPI bags using a microwave plasma atomic emission spectrometer: not so easy for the pharmacist! C. Salvez, L. Delnoy, E. Baba, C. Monchy, , W. David, C. Skorka, S. Bulcourt, D. Dautel.
Valenciennes Hospital Center - France
Development and validation of an analytical method for the assessment of methylparaben and propylparaben by HPLC-UV A. Sauvaget, J. Robin, G. Binson, A. Dupuis
Hôpital universitaire de Poitiers, France
Development and validation of an analytical method for the determination of thiopental for a physicochemical stability study J. Robin1, N. Hami1, A. Sauvaget1, K. Cheroux2, G. Binson1, A. Dupuis1.
1: Pharmacy department, University Hospital of Poitiers, France.
2: Gynaecology department, University Hospital of Poitiers, France.
Oral suspension of spironolactone: development and validation of an analytical method by HPLC-UV A. Musicki1, C. Merienne2, C. Marchand2, M. Breniaux1, T. Quessada1
1 : Pharmacie, Hôpital Edouard-Herriot, Lyon, France
2 : Pharmacie, Hôpitaux Louis Pradel, Lyon, France
Validation of an alternative method for sterility control of parenteral nutrition mixtures J-C. Mabin, C. Tournus, C. Chaplain, A. Diallo, X. Deviot
Centre Hospitalier de Saint-Denis, France

E-Posters session B: Contamination - Microbiologiy - Stability

Evolution of chemical contamination in a Cytotoxic Reconstitution Unit J. Gallot-Lavallée, S. Himoudi, I. Hennebelle, Y. Cretu, M. Caucat, S. Herioux, F. Puisset, S. Perriat, JM. Canonge
Institut Universitaire du Cancer de Toulouse - Oncopôle, France
Clean room : mapping of microbiological samples of the environment using a Failure Mode an Effect Analysis (FMEA) method F. Rivals, G. Bouguéon, M. Sangnier, M. Saly, H. Boulestreau, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France
Stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin IV bags V. Vieillard, M. Paul
CHU Henri Mondor, Créteil, France
Physicochemical stability of daratumumab SC (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature L. Knoll, J. Thiesen, M. Klaßen, L. Reinders, J. Türk, I. Krämer
University Medical Center Mainz, Germany
Physicochemical stability study of cabazitaxel Zentiva® in vials after “opening” and in diluted solutions in 3 types infusion bags E. D’Huart, M. Sacrez, N. Sobalak, J. Vigneron, B. Demore
CHU Nancy, Infostab, France
A study of the stability of Ceftriaxone preparations in two vehicles for epicutaneous allergy tests I. Belaid, T. Pereira, H. Gondé, M. Cavelier, F. Lamoureux, R. Varin, C. Hervouet
Hôpital Lariboisière, AP-HP Paris, CHU Rouen, France
Microbial contamination of isolators: from risk analysis to decision-making flowchart E. Seguin, S. Martelli, M-L. Brandely-Piat, M. Jobard, R. Batista
Université de Paris Cité - site Cochin, Paris, France
Evaluation of surface contamination with cyclophosphamide and paclitaxel to control the risk of occupational exposure to hazardous drugs in two hospitals of a comprehensive cancer center C. Ulian, J. Fouque, M. Lafay, C. Matta, N. Subramanian, O. Collin, S. Huguet, K. Rezai, O. Madar,
R. Desmaris, L. Escalup, B. Haney-Teillaud, A. Acramel
Institut Curie, Paris
Biological stability of Durvalumab solutions in its opened vials or after dilution and storage in 0.9% NaCl infusion polyolefin bags A. Acramel, G. Le Guyader, K. Avrillon, L. Guyonnet, J. Denizeau, L. Escalup, R. Desmaris, E. Piaggio, C. Guerin, C. Sedlik
Institut Curie Paris, Hôpital Henri Mondor AP-HP Paris, CHI Créteil, France
Microbiological stability of Rituximab bags A. Iwanoff, C. Djayet, A-S. Martin, C. Davoine, F. El Alaoui, M. Rigal, A. Jacolot, M. Apparuit
Hôpital Avicenne, Bobigny, France
Improving flows to limit particulate contaminants in sterile preparation areas F. Giannelli, C. Figeac, M-D. Desruet, M. Durand, P. Bedouch
Centre Hospitalier Universitaire Grenoble Alpes, France
Method validation in preservation of sterile agar plates beyond the manufacturers’ recommendations for use in a compounding unit M. Caudron, N.D. Alloh, A. Nowak, A. Fillatre, M. Royer, L. Mustapha, F. Marçon
CHU Amiens, France

E-Posters session C: Quality Assurance

Risk analysis relating to the implementation of a circuit of advanced therapies medicinal products in a comprehensive cancer center R. Rekik, A. Acramel, O. Andre, L. Hammoudi, A. Bouyarden, L. Escalup
Institut Curie, Paris, France
Constraints and feasibility of filter integrity testing for the production of sterile preparations in hospital pharmacy K. Tardivel, P. Lemoine, E. Fischer, M. Pichon-Pramil, C. Merienne, B. Lapras, M. Cristofoli, C. Marchand, F. Pirot
Groupement Hospitalier Edouard Herriot - Hospices Civils de Lyon, France
Feedback: Is it useful to watch all DRUGCAM® videos before delivery? M. Viault, P. Marque, N. Soulet, B. Darricau, T. Boulet, M. Anquetil, S. Rajezakowski
Centre Hospitalier de Niort, France
Retrospective differential analysis between 3971 prescriptions of individualized parenteral nutrition and 2 commercial parenteral nutrition M. Royer, A. Léké, F. Marçon
CHU d’Amiens, France
Implementation of a continuity plan for Cytotoxic Reconstitution Unit (CRU) in case of cyberattack R. Gallerand, C. Brentot, E. Sigward, M. Andanson-Macchi
CH Montluçon, France
Is the chemotherapy circuit with RFID technology a good idea? A. Loison, C. Skorka, D. Dautel, F. Verryser
Centre Hospitalier de Valenciennes, France
Visual management SQCDP: a tool for monitoring performance in pharmacotechny unit A. Lassalle-Diguet, A. Andrieu, E. Raingeard, Y. Poirier
CHD Vendée, La Roche sur Yon, France
Performance qualifications of sterilization cycle in isolator: Are the qualifications carried out by the manufacturer indisputable? C. Cros, A. Hurgon, A. Acramel, G. Jacquemmoz, R. Desmaris, L. Escalup
Institut Curie, Paris, France
Causes determination of noncompliance in the measurement of calcium in parenteral nutrition mixtures J. Nakache, N. Gastaut, H. Baaziz, J. Duquesne, G. Chinetti, S. Ruitort, R. Collomp
CHU de Nice, France
« Done for Mrs B ! » : Comparison of a chemotherapy oral validation versus a conventional validation circuit S. Winckel, A. Danckaert, H. Huyghe, D. De Bertoult, P. Carlier, S. Fernandez, L. Real
Centre Hospitalier d’Arras, France
Optimisation of the organisation of a Chemotherapy Reconstitution Unit in a French Oversea Territory – Dose standardisation of paclitaxel W. Bopp, S. Istin, A. Zavarro, F. Gonnet, P. Dupire
Centre Hospitalier de Polynésie Française, Papeete, Tahiti
Performance qualification (PQ) of a new isolator for reconstitution of cytotoxics J. Gotzamanis, G. Bouguéon, M. Sangnier, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France

E-Posters session D: Formulation - Production

Dose-capping, dose-adjustment, full-dose: what to do for antineoplastic drugs in obese patients ? J. Gouju, A. Ifrah, M. Delamotte, L. Le Quay, A. Lebreton, F. Lagarce
CHU d’Angers, France
Formulation, particle size and rheological characterization of a pediatric suspension of prazosin for the treatment of post-traumatic night terrors M. Cristofoli, P. Espi, C. Moreau, C. Paillet, C. Marchand, M. Pichon-Pramyl, C. Merienne, F. Pirot
Groupement Hospitalier Edouard Herriot - Hospices Civils de Lyon, France
177Lu-ITG-PSMA-1: Development of a fully automatized in-hospital production J. Delage, J. Costes, K. Casagrande, T. Baumgartner, J. Caputo, J. De Figueiredo, O. Fabre, P. Houlmann, F. Sadeghipour
HU de Lausanne, Suisse
Development and validation of [18F]DPA714 automated radiosynthesis, a PET radiotracer for neuroinflammation imaging A. Zavarro, V. Nail, A. Moyon, P. Garrigue, A. Bouhlel, B. Guillet
Centre Européen de Recherche en Imagerie, Marseille, France
Spiros® and small administration volume: gravimetric control helps limit waste C. Brentot, E. Sigward, M. Andanson-Macchi
CH Montluçon Néris-les-Bains, France
Assessment of the Bexen Medical Col system to prepare autologous serum eyes drops A. Daujat, V. Dias Meireles, L. Rabouam, F. Vallee, A-C. Epinette
Centre Hospitalier Universitaire de Poitiers, France
Radiolabelling of erythrocytes with 18FDG : feasibility study J. Costes, J. Delage, K. Casagrande, J. Prior, F. Sadeghipour
HU de Lausanne, Suisse
Haloperidol nasal solution: formulation and physicochemical stability study A. Ressault, A. Dory, L. Perello, L. Gheddar, P. Kintz, G. Ubeaud Séquier, B. Gourieux
CHU de Strasbourg, France
Development of vinorelbine oral formulations for pediatric use L. Macqueron, L. Regnier, P. Robinet, A-L. Leroy, M-A. Lester, P-N. Boivin, P. Le Corre
Centre Hospitalier Universitaire de Rennes, France
Administration devices for oral compounding M. Cavelier, H. Gondé, C. Orsini, A. Coquard, R. Varin, C. Hervouët
CHU de Rouen, France
110 Development and stability of 40 mg/mL amiodarone oral suspension M. Cavelier, H. Gondé, D. Costa, F. Lamoureux, T. Pereira, R. Varin, C. Hervouët
CHU de Rouen, France

E-Posters session E: Production

Waste of hospital preparations, the example of ceftazidime ophthalmic solution at Angers University Hospital S. Maisonneuve, V. Lebreton, S. Vrignaud, F. Lagarce
Centre hospitalier universitaire d’Angers, France
Hospital preparations : towards the automation of their packaging N. Kervella, A. Bourges, M. Bernard, S. Vrignaud, V. Lebreton
CHU d’Angers, France
Emergency opening of sterile preparations unit during COVID-19 pandemic E. Gasperi, F. Bordet, M-L. Maestroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
Methotrexate for ectopic pregnancies: a national survey on pharmacy practice I. Challier, M. Le Goff, M. Zeino, S. Chatain, C. Orsini, A. Coquard, R. Varin
CHU de Rouen, France
Feedback on 5 months of use of a robotized production system in the Cytotoxic Reconstitution Unit M-L. Ducassou, G. Gaschard, M. Bay
CHU de Poitiers, France
Residual volume of anticancer drugs when administering a preparation with filter tubing: What solution? M. Chabert, M. Duval, C. Alessandra
Hôpital Sainte Musse, Toulon, France
Manufacturing practices, formulations and reimbursement of topical forms of apamycin in Tuberous Sclerosis of Bourneville: update on French practices A. Moussali, R. Mazet, M Durand, J. Leenhardt, M-D. Desruet, P. Bedouch
Centre Hospitalier Universitaire Grenoble Alpes, France
Feedback from temporary relocation of a sterile production activity M. Sangnier, G. Bougueon, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France
Production of an injectable bacteriophage preparation: identification of the associated critical points L. Delnoy, D. Lannoy, B. Palas, M. Roche, C. Berneron, M. Titecat, P. Odou
CHU de Lille, France
Subcontracting of the reconstitution of anti-cancer drugs: feedback from the principal 2 years after implementation G. Pottier, E. Desaintfuscien, J. Courtin, M. Vasseur, P. Odou, A. Deswarte
CH d’Armentières, CHU de Lille, France
Implementation of dose-banding in our hospital: ready-to-infuse bags or standardized dose batches S. Couture, M. Malassigné, MC. Casaurancq, C. Burtin
Centre Hospitalier de la Côte Basque, Bayonne, France
Impact study of eye drop batch production. X Impact study of eye drop batch production C. Rode, O. Chopart, A. Khan, B. Dessane, V. Servant, A. Venet, S. Crauste-Manciet
CHU de Bordeaux, Franc

Photos

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data
Réalisation : studiomaiis.net - développeur web freelance